OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$12.94 USD
+0.64 (5.20%)
Updated May 24, 2024 03:59 PM ET
After-Market: $12.95 +0.01 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
Brokerage Reports
OptimizeRx Corp. [OPRX]
Reports for Purchase
Showing records 1 - 20 ( 123 total )
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Rebound Emergence Confirmed by 1Q24 Pre-Announcement DAAP Momentum
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Preliminary Earnings Data Support Bullish Thesis
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Acquisition and Cost Controls Set To Increase Revenue and Earnings Scale
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Slow Growth Rebound Emerging But Behind Expectations; PT Cut to $20.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Midyear Strategic Update" Affirms Growth Rebound Expectation
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Pharma Spending Weakness Persists But Glimmers of Hope Emerging
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Weak Yr/Yr Results Belie Early Strength Signals From New RWE Offering
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Downside Results Widely Miss; Cutting Price Target to $31.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R